Skip to search formSkip to main contentSkip to account menu

Naltrexone

Known as: 17-(Cyclopropylmethyl)-4,5-epoxy-3,14-dihydroxymorphinan-6-one, Naltrexonum, N-Cyclopropylmethylnoroxymorphone 
A noroxymorphone derivative with competitive opioid antagonistic property. Naltrexone reverses the effects of opioid analgesics by binding to the… 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2003
Highly Cited
2003
This study examined the association between two specific polymorphisms of the gene encoding the μ-opioid receptor and treatment… 
Highly Cited
2002
Highly Cited
2002
Abstract.Background: This laboratory study investigated the mechanisms by which the opioid antagonist, naltrexone, reduces the… 
Highly Cited
2000
Highly Cited
2000
Improvement of uremic pruritus was reported under short-term administration of the mu-receptor antagonists naltrexone and… 
Highly Cited
1997
Highly Cited
1997
BACKGROUND & AIMS The efficacy of currently available therapeutic agents for cholestatic pruritus is often disappointing. The aim… 
Highly Cited
1995
Highly Cited
1995
OBJECTIVE Subjective effects of alcohol in alcoholics treated with naltrexone or placebo were compared. METHOD In a previously… 
Highly Cited
1992
Highly Cited
1992
Ninety-seven alcohol-dependent patients were treated for 12 weeks in a double-blind, placebo-controlled study evaluating… 
Highly Cited
1979
Highly Cited
1979
The Rand report achieved coast to coast media coverage and generated a lot of heat simply because it was found that, out there in…